首页> 外文OA文献 >The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity

【2h】

The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity

机译：乳腺癌，早期疾病：表阿霉素治疗的毒性 - 心脏评估和风险评估（BETTER-CaRE）研究：CmR与早期钆相对增强，但不是高敏感肌钙蛋白T，预测慢性蒽环类药物心脏毒性的风险

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Kotwinski Paul; Smith Gillian; Sanders Julie; Ma Louise; Cooper Jackie; Thomas Michael; Mythen Michael (Monty) G; Jones Alison; Montgomery Hugh E; Pennell Dudley J;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chroni [J] . Paul Kotwinski, Gillian Smith, Julie Sanders, Journal of cardiovascular magnetic resonance : . 2013,第Suppla1期

机译：乳腺癌，早期疾病：表柔比星疗法治疗的毒性-心脏评估和风险评估（BETTER-CARE）研究：早期g相对增强而不是高敏感性肌钙蛋白T的CMR可以预测发生慢性的风险
2. The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chroni [J] . Paul Kotwinski, Gillian Smith, Julie Sanders, Journal of cardiovascular magnetic resonance : . 2013,第Suppla1期

机译：乳腺癌，早期疾病：表柔比星疗法治疗的毒性-心脏评估和风险评估（BETTER-CARE）研究：早期g相对增强而不是高敏感性肌钙蛋白T的CMR可以预测发生慢性的风险
3. A pilot study to investigate high-sensitivity cardiac troponin I (hscTnI) and high-sensitivity cardiac troponin T (hscTnT) for the prediction of cardiotoxicity in women with breast cancer treated with doxorubicin or trastuzumab [J] . Utsumi T., Ishii J., Naruse H., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2018,第期

机译：试验研究，以研究高敏感性心肌肌钙蛋白I（HSCTNI）和高敏感性心肌肌钙蛋白T（HSCTNT）对乳腺癌或曲妥珠单抗治疗的乳腺癌患者心脏毒性的预测
4. The breast cancer early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement but not high-sensitivity troponin T predicts the risk of chronic anthracycline cardiotoxicity [O] . Paul Kotwinski, Gillian Smith, Julie Sanders, 2013

机译：乳腺癌早期疾病：表柔比星疗法治疗的毒性-心脏评估和风险评估（BETTER-CARE）研究：早期relative相对增强而不是高敏感性肌钙蛋白T的CMR预测了慢性蒽环类药物具有心脏毒性的风险
5. The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity [O] . Paul Kotwinski, Gillian Smith, Julie Sanders, 2017

机译：乳腺癌，早期疾病：表柔比星疗法治疗的毒性-心脏评估和风险评估（BETTER-CARE）研究：早期relative相对增强而不是高敏感性肌钙蛋白T的CMR预测了慢性蒽环类药物具有心脏毒性的风险

The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chronic anthracycline cardiotoxicity

著录项

相似文献

相关主题

期刊订阅